Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 90.00
+1.50 (1.69%)
Sep 25, 2026, 9:02 AM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 33.41 million as of September 24, 2026. Its market cap has increased by 22.07% in one year.
Market Cap
33.41M
Enterprise Value
27.38M
Revenue
1.71M
Ranking
n/a
PE Ratio
44.25
Stock Price
90.00
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 33.41M, a decrease of -50.12%. That is a compound annual growth rate of -12.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 33.41M | 9.94% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 72.29M |
| Poolbeg Pharma | 68.71M |
| Ondine Biomedical | 55.85M |
| Sareum Holdings | 42.96M |
| Hemogenyx Pharmaceuticals | 31.96M |
| ImmuPharma | 22.89M |
| IXICO | 16.42M |
| SkinBioTherapeutics | 16.20M |